CINECA IRIS Institutional Research Information System

RUBATTO, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 843
EU - Europa 269
AS - Asia 105
AF - Africa 10
Continente sconosciuto - Info sul continente non disponibili 5
SA - Sud America 2
Totale 1.234
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 842
IE - Irlanda 86
IT - Italia 84
CN - Cina 49
SE - Svezia 48
IN - India 23
DE - Germania 12
SG - Singapore 12
NG - Nigeria 10
BE - Belgio 8
KR - Corea 7
JP - Giappone 6
UA - Ucraina 6
EU - Europa 5
MY - Malesia 5
RU - Federazione Russa 5
FI - Finlandia 4
GB - Regno Unito 3
RO - Romania 3
AT - Austria 2
FR - Francia 2
HK - Hong Kong 2
SI - Slovenia 2
BR - Brasile 1
CA - Canada 1
CH - Svizzera 1
CL - Cile 1
DK - Danimarca 1
GR - Grecia 1
NL - Olanda 1
TR - Turchia 1
Totale 1.234
Salva come PNG Salva come JPEG
Città #
Chandler 310
Dublin 86
Ashburn 52
Nyköping 43
Princeton 28
Medford 24
Boston 18
Hebei 17
Pune 17
Turin 17
Fairfield 15
New York 12
Milan 11
Abuja 10
Ann Arbor 10
Hangzhou 10
Beijing 9
Singapore 9
Brussels 8
Chengdu 7
Seattle 7
Seoul 7
Torino 7
Cambridge 6
Wilmington 6
Woodbridge 5
Chennai 4
Moscow 4
Mountain View 4
Parma 4
Washington 4
Bari 3
Castiglione Olona 3
Lappeenranta 3
Redmond 3
Adrano 2
Arezzo 2
Berlin 2
Bologna 2
Guiyang 2
Houston 2
Hyderabad 2
Kuala Lumpur 2
Ljubljana 2
London 2
L’Aquila 2
Montelupone 2
Norwalk 2
Perugia 2
Pescara 2
Putrajaya 2
San Diego 2
Atlanta 1
Baricella 1
Castel San Pietro Terme 1
Chioggia 1
Clearwater 1
Como 1
Denizli 1
Eitensheim 1
Esslingen am Neckar 1
Falls Church 1
Frankfurt am Main 1
Frederick 1
Galati 1
Helsinki 1
Henderson 1
Kajang 1
Naples 1
Philadelphia 1
Piraeus 1
Provo 1
Québec 1
Redwood City 1
Renens 1
Rome 1
Santa Clara 1
Santiago 1
Scafati 1
Shenyang 1
Slough 1
Stuttgart 1
Suceava 1
São Paulo 1
Upper Marlboro 1
Vidin 1
Totale 851
Salva come PNG Salva come JPEG
Nome #
Immunotherapy in Xeroderma Pigmentosum: A case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review 73
Immunotherapy in transplanted patients: A special population that can no longer be ignored 66
Anti-BRAF/anti-MEK targeted therapies for metastatic melanoma patients during the COVID-19 outbreak: Experience from an Italian skin cancer unit 54
Acute appendicitis secondary to desmoplastic melanoma metastasis in immune-checkpoint inhibitors era 52
Cutaneous side effects and types of dermatological reactions in metastatic melanoma patients treated by immunotherapies or targeted therapies: A retrospective single center study 52
The Effect of the COVID-19 Lockdown on Melanoma Diagnosis in Italy 51
Biologic treatment for psoriasis in cancer patients: should they still be considered forbidden? 50
Clinical significance of distant metastasis-free survival (Dmfs) in melanoma: A narrative review from adjuvant clinical trials 50
Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary Syndrome 49
Case Report: Atypical Cutaneous Presentation of Human T-cell Lymphotropic Virus Type 1-Related Adult T-cell Lymphoma 48
Prognostic and predictive biomarkers in stage iii melanoma: Current insights and clinical implications 44
Melanoma management during the covid-19 pandemic emergency: A literature review and single-center experience 43
Metastatic melanoma treatment with checkpoint inhibitors in the COVID-19 era: experience from an Italian Skin Cancer Unit 42
Extensive "halo naevi" phenomenon and regression of melanin during nivolumab treatment in metastatic melanoma: A predictor of a better outcome? 42
Association between Primary Cutaneous B-cell Lymphomas and Other Skin Cancers: A Multicentre Cohort Study 41
Misuse, consequences and phototoxic skin-related effects of Rutaceae: a comprehensive literature review 39
Ruta graveolens phytophotodermatìtis 39
Risankizumab shows high efficacy and maintenance in improvement of response until week 52 38
Patients with psoriasis resistant to multiple biological therapies: characteristics and definition of a difficult-to-treat population 33
Patients with locally advanced and metastatic cutaneous squamous cell carcinoma treated with immunotherapy in the era of COVID-19: stop or go? Data from five Italian referral cancer centers 30
Predictive value of baseline [18f]fdg pet/ct for response to systemic therapy in patients with advanced melanoma 30
Treatment of Advanced Metastatic Melanoma 29
Real-life comparison between secukinumab and ixekizumab in the treatment of pustular and erythrodermic psoriasis 28
Treatment of early-stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Study (PROCLIPI study) 27
Data of Italian Cancer Centers from two regions with high incidence of SARS CoV-2 infection provide evidence for the successful management of patients with locally advanced and metastatic melanoma treated with immunotherapy in the era of COVID-19 27
Sézary Syndrome: Different Erythroderma Morphological Features with Proposal for a Clinical Score System 26
Clinical evaluation of hydration index using a corneometer in metastatic melanoma patients treated with BRAF/MEK inhibitors: a prospective study 24
Risk of Reactivation of Latent Tuberculosis in Psoriasis Patients on Biologic Therapies: A Retrospective Cohort from a Tertiary Care Centre in Northern Italy 24
Addendum: Immunotherapy in Xeroderma Pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review 19
Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma 19
Dramatic response of face desmoplastic melanoma after two doses of immunotherapy 17
Sentinel Lymph Node Biopsy in Malignant Melanoma of the Head and Neck: A Single Center Experience 17
Nonmelanoma skin cancer arising on tattoos 16
Perspectives of immunotherapy in non-melanoma skin cancers 14
Regression of human papillomavirus-associated high-grade vaginal intraepithelial neoplasia after switching from ustekinumab to risankizumab in a psoriasis patient 11
Liver metastases and immunotherapy: A barrier to response for metastatic melanoma 11
Primary cutaneous lymphoma patients seen at a referral dermatological centre in 1 year: A single-centre observational retrospective cohort study of the diagnoses and staging, comorbidities and associated symptoms, treatment performed and clinical course 9
Classic and new strategies for the treatment of advanced melanoma and non-melanoma skin cancer 4
Discontinuation of anti-PD1 in advanced melanoma: an observational retrospective study from the Italian Melanoma Intergroup 3
The Analysis of Trends in Survival for Patients with Melanoma Brain Metastases with Introduction of Novel Therapeutic Options before the Era of Combined Immunotherapy-Multicenter Italian-Polish Report 2
Exploring the role of epigenetic alterations and non-coding RNAs in melanoma pathogenesis and therapeutic strategies 2
Switching from IL23 inhibitors to IL17 inhibitors: A safe and effective practice? 1
Advanced Cutaneous Squamous Cell Carcinoma: Italian Multicentric Retrospective Analysis of Patient Profiles and Therapeutic Approaches 1
BRAFV600 variant allele frequency predicts outcome in metastatic melanoma patients treated with BRAF and MEK inhibitors 1
A retrospective observational study on cutaneous adverse events induced by immune checkpoint inhibitors 1
Totale 1.299
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.517
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.517
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217 0 0 0 0 0 0 2 3 0 0 0 2
2021/2022339 36 7 8 9 63 19 13 10 13 8 55 98
2022/2023668 57 87 10 63 69 137 32 56 71 16 44 26
2023/2024285 36 66 19 26 18 81 2 15 1 21 0 0
Totale 1.299